Nipro Corporation (NISOF) 8.6480 $NISOF
U.S. Glucose Testing Markets 2014: Clinical Measurement Devices, Reagents and Supplies as Utilized in Hospitals, Clinics, Doctor's Offices and At-Home Care Locations
M2 - Mon Feb 02, 2:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/dl4jfq/u_s_glucose) has announced the addition of the "U.S. Glucose Testing Markets 2014: Clinical Measurement Devices, Reagents and Supplies as Utilized in Hospitals, Clinics, Doctor's Offices and At-Home Care Locations" report to their offering. This report describes the specific market segments for blood glucose testing and diabetes management in the U.S. market. It reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum, plasma or whole-blood glucose concentrations. Additionally, this study examines clinical measurement devices, reagents and supplies as utilized in hospitals, clinics, doctor's offices and at-home care locations. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, several segments of the market, such as home testing devices for diabetes management and point of care (POC) instruments for use in professional settings, will exhibit strong growth. Direct access testing has emerged as a strong force in the blood glucose testing segment, and non-invasive and minimally-invasive testing now represent major new areas for the application of IVD testing. U.S. Glucose Testing Markets 2014 analyzes almost all of the companies known to be marketing, manufacturing or developing glucose testing products for the U.S. market. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included. Key Topics Covered: 1. Overview 2. Diabetes 3. Market Analysis: Size, Growth, Share and Competitors 4. Glucose Diagnostic and Monitoring Recommendations 5. Glucose Testing Technology Platforms and Consumable Products 6. Glucose Testing Devices on the Market 7. Business Trends in Glucose Testing 8. Technology Trends 9. Company Profiles - Click the link below to view the full list of companies featured in this extensive report - Abaxis, Inc. - Abbott Laboratories - AgaMatrix - B. Braun Melsungen - Beckman Coulter - Bionime - Bio-Rad Laboratories, Inc. - BioTex - Calisto Medical - Cambridge Sensors - DexCom - Diagnostic Devices/Prodigy Diabetes Care - DiaSys - Echo Therapeutics - GlySens - GlySure Limited - Grove Instruments - Hainice Medical - HemoCue (a Quest Diagnostics company) - Johnson & Johnson - Luminous Medical - Medtronic - Nipro Corporation - Nova Biomedical - OrSense - Polymer Technology Systems - Radiometer Medical - Roche - 77 Elektronika Kft. - Siemens AG For more information visit http://www.researchandmarkets.com/research/dl..._s_glucose
ECTE: 2.62 (+0.06), JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), MDT: 75.26 (+0.33), ABAX: 60.93 (+0.65)
Dialysis Products and Services Market Report - Global Industry Analysis 2014-2020
M2 - Thu Nov 27, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/55wbqr/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. This report studies the global market for dialysis products and services from three major perspectives: product type, service type and geography. The stakeholders of this study include existing companies manufacturing dialysis products or providing dialysis services to the patients and new entrants who are planning to invest in this market. The report comprises of an executive summary section that provides a snapshot of the market with succinct information about market size and growth of different product segments, services, market share and geographic analysis of the global dialysis products and services market. The market overview section illustrates about the global market dynamics and trends comprising of drivers, restraints and opportunities that influence the current and future status of the dialysis products and services market. Several other factors such as market share analysis by major market players and Porter's five force analysis are also included in this report providing a thorough analysis about the competitive scenario in the global dialysis products and services market. Further, the market overview section also includes regulatory scenario of dialysis products and services market at global scale along with the announcements and guidelines by important bodies such as Food and Drug Administration (FDA) and Association for the Advancement of Medical Instrumentation (AAMI). These factors are explained thoroughly to help the market players in planning their strategies which will help them in expanding their presence and in strengthening their position in the global market. Report Scope Dialysis Products and Services Market, by Product type: - Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) - Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/55...s_products
NXTM: 17.56 (-0.05), BAX: 70.39 (+0.31), RMTI: 11.17 (+0.15), CMN: 44.28 (+1.09)
Nipro Medical Corporation Introduces the First Dialyzer in the US without BPA or DEHP at the American Society of Nephrology Kidney Week 2014
Business Wire - Tue Nov 11, 7:00AM CST
Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing, announced at Kidney Week 2014, the launch of the next generation ELISIO(TM) POLYNEPHRON(TM) Single Use, High-Flux, Hollow-Fiber Dialyzer. This is a superior version of the ELISIO dialyzer that was launched early this year. Both the housing and the membrane are made with material not containing BPA or DEHP. ELISIO(TM) features a state-of-the-art POLYNEPHRON(TM) membrane similar in function to that of a human kidney, delivering outstanding solute-removal performance, resulting in superior clearances for better patient outcomes.
Infraredx Receives Regulatory Approval of TVC Imaging System in Japan
Business Wire - Mon Sep 29, 7:00AM CDT
Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that its first-in-class, dual-modality intravascular imaging technology, TVC Imaging System(TM), and its TVC Insight(TM) Catheter received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW). The TVC System makes it possible to determine the structure and chemical composition of the coronary plaques that complicate stenting, and are associated with heart attacks. The TVC Imaging System console and catheter will be exclusively distributed by Goodman, a subsidiary of Osaka-based Nipro Corporation, which has extensive experience commercializing IVUS and other imaging technologies in Japan.
Global Dialysis Products and Services (Hemodialysis Products, Peritoneal Dialysis Products
M2 - Thu Sep 11, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c8vw2r/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future. The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis. Dialysis Products and Services Market, by Product type: Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/c8...s_products
NXTM: 17.56 (-0.05), BAX: 70.39 (+0.31), RMTI: 11.17 (+0.15), CMN: 44.28 (+1.09)
World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada ) 2013-2017
M2 - Mon Jun 30, 2:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9cd736/the_world_market) has announced the addition of the "The World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada )" report to their offering. This report looks at both the equipment and service aspects of the dialysis industry. The industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments -- the medical device industry (dialysis products and supplies segment) and the healthcare services industry (dialysis services segment). The dialysis industry remains a robust, multi-billion dollar business that has managed to fuel its growth engine in the past 5 years. What makes this market more interesting and challenging is its relatively small customer base - a bit under two million dialysis patients form its entire universe. It is the high value of these customers that make this a competitive industry. Key Data and Analysis in this report includes: - Detailed Forecasts to 2017 - In-Depth Profiles of the Competitive Companies in Dialysis Treatment, Equipment and Supplies. - Scores of Figures and Tables featuring useful data, demographic and market trends that can be used to supplement internal memos or presentation. - Detailed World Dialysis Market Review including specific reviews of the dialysis service, equipment and supplies market in the United States, Japan, UK, Italy, India, China and Australia and Canada. - Market Share of Major Care and Equipment Providers. - The Changing Regulatory Environment. - Detailed Patient Demographics Current Data, Forecasts and Trends. Issues and trends explored in this study include: - Innovation Pathway at FDA - Dialyzers - Prismaflex System Software - Wearable Artificial Kidney - Implantable Artificial Kidney - Prevalence of Diabetes in Developing Regions - Insurance and Reimbursement Issues - Access to Care for Native Populations - Kidney Transplantation - Product Development and Innovation - Consolidation and Joint Ventures in the Industry - Home Dialysis - Heat Disinfection for Water Quality - Dialysis Treatment Comfort Company Profiles - Asahi Kasei Medical - B.Braun AG - Baxter Healthcare - Bellco - DaVita - Diaverum - Fresenius Medical Care - Fuso Pharmaceutical - Gambro AB - Kawasumi Laboratories - Medionics International - Nikkiso Medical - Nipro Corporation - NxStage Medical For more information visit http://www.researchandmarkets.com/research/9c...rld_market
NXTM: 17.56 (-0.05)
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.
CAH: 86.08 (+0.04), KMB: 111.00 (+0.82), ETRM: 1.21 (+0.06), IVC: 17.13 (+0.15), BAX: 70.39 (+0.31), HRC: 46.88 (+0.14), SYK: 94.51 (+1.14)
U.S. Glucose Testing Markets 2014: Clinical Measurement Devices, Reagents and Supplies as Utilized in Hospitals, Clinics, Doctor's Offices and At-Home Care Locations
M2 - Mon Feb 02, 2:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/dl4jfq/u_s_glucose) has announced the addition of the "U.S. Glucose Testing Markets 2014: Clinical Measurement Devices, Reagents and Supplies as Utilized in Hospitals, Clinics, Doctor's Offices and At-Home Care Locations" report to their offering. This report describes the specific market segments for blood glucose testing and diabetes management in the U.S. market. It reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum, plasma or whole-blood glucose concentrations. Additionally, this study examines clinical measurement devices, reagents and supplies as utilized in hospitals, clinics, doctor's offices and at-home care locations. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, several segments of the market, such as home testing devices for diabetes management and point of care (POC) instruments for use in professional settings, will exhibit strong growth. Direct access testing has emerged as a strong force in the blood glucose testing segment, and non-invasive and minimally-invasive testing now represent major new areas for the application of IVD testing. U.S. Glucose Testing Markets 2014 analyzes almost all of the companies known to be marketing, manufacturing or developing glucose testing products for the U.S. market. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included. Key Topics Covered: 1. Overview 2. Diabetes 3. Market Analysis: Size, Growth, Share and Competitors 4. Glucose Diagnostic and Monitoring Recommendations 5. Glucose Testing Technology Platforms and Consumable Products 6. Glucose Testing Devices on the Market 7. Business Trends in Glucose Testing 8. Technology Trends 9. Company Profiles - Click the link below to view the full list of companies featured in this extensive report - Abaxis, Inc. - Abbott Laboratories - AgaMatrix - B. Braun Melsungen - Beckman Coulter - Bionime - Bio-Rad Laboratories, Inc. - BioTex - Calisto Medical - Cambridge Sensors - DexCom - Diagnostic Devices/Prodigy Diabetes Care - DiaSys - Echo Therapeutics - GlySens - GlySure Limited - Grove Instruments - Hainice Medical - HemoCue (a Quest Diagnostics company) - Johnson & Johnson - Luminous Medical - Medtronic - Nipro Corporation - Nova Biomedical - OrSense - Polymer Technology Systems - Radiometer Medical - Roche - 77 Elektronika Kft. - Siemens AG For more information visit http://www.researchandmarkets.com/research/dl..._s_glucose
ECTE: 2.62 (+0.06), JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), MDT: 75.26 (+0.33), ABAX: 60.93 (+0.65)
Dialysis Products and Services Market Report - Global Industry Analysis 2014-2020
M2 - Thu Nov 27, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/55wbqr/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. This report studies the global market for dialysis products and services from three major perspectives: product type, service type and geography. The stakeholders of this study include existing companies manufacturing dialysis products or providing dialysis services to the patients and new entrants who are planning to invest in this market. The report comprises of an executive summary section that provides a snapshot of the market with succinct information about market size and growth of different product segments, services, market share and geographic analysis of the global dialysis products and services market. The market overview section illustrates about the global market dynamics and trends comprising of drivers, restraints and opportunities that influence the current and future status of the dialysis products and services market. Several other factors such as market share analysis by major market players and Porter's five force analysis are also included in this report providing a thorough analysis about the competitive scenario in the global dialysis products and services market. Further, the market overview section also includes regulatory scenario of dialysis products and services market at global scale along with the announcements and guidelines by important bodies such as Food and Drug Administration (FDA) and Association for the Advancement of Medical Instrumentation (AAMI). These factors are explained thoroughly to help the market players in planning their strategies which will help them in expanding their presence and in strengthening their position in the global market. Report Scope Dialysis Products and Services Market, by Product type: - Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) - Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/55...s_products
NXTM: 17.56 (-0.05), BAX: 70.39 (+0.31), RMTI: 11.17 (+0.15), CMN: 44.28 (+1.09)
Nipro Medical Corporation Introduces the First Dialyzer in the US without BPA or DEHP at the American Society of Nephrology Kidney Week 2014
Business Wire - Tue Nov 11, 7:00AM CST
Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing, announced at Kidney Week 2014, the launch of the next generation ELISIO(TM) POLYNEPHRON(TM) Single Use, High-Flux, Hollow-Fiber Dialyzer. This is a superior version of the ELISIO dialyzer that was launched early this year. Both the housing and the membrane are made with material not containing BPA or DEHP. ELISIO(TM) features a state-of-the-art POLYNEPHRON(TM) membrane similar in function to that of a human kidney, delivering outstanding solute-removal performance, resulting in superior clearances for better patient outcomes.
Infraredx Receives Regulatory Approval of TVC Imaging System in Japan
Business Wire - Mon Sep 29, 7:00AM CDT
Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that its first-in-class, dual-modality intravascular imaging technology, TVC Imaging System(TM), and its TVC Insight(TM) Catheter received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW). The TVC System makes it possible to determine the structure and chemical composition of the coronary plaques that complicate stenting, and are associated with heart attacks. The TVC Imaging System console and catheter will be exclusively distributed by Goodman, a subsidiary of Osaka-based Nipro Corporation, which has extensive experience commercializing IVUS and other imaging technologies in Japan.
Global Dialysis Products and Services (Hemodialysis Products, Peritoneal Dialysis Products
M2 - Thu Sep 11, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c8vw2r/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future. The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis. Dialysis Products and Services Market, by Product type: Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/c8...s_products
NXTM: 17.56 (-0.05), BAX: 70.39 (+0.31), RMTI: 11.17 (+0.15), CMN: 44.28 (+1.09)
World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada ) 2013-2017
M2 - Mon Jun 30, 2:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9cd736/the_world_market) has announced the addition of the "The World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada )" report to their offering. This report looks at both the equipment and service aspects of the dialysis industry. The industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments -- the medical device industry (dialysis products and supplies segment) and the healthcare services industry (dialysis services segment). The dialysis industry remains a robust, multi-billion dollar business that has managed to fuel its growth engine in the past 5 years. What makes this market more interesting and challenging is its relatively small customer base - a bit under two million dialysis patients form its entire universe. It is the high value of these customers that make this a competitive industry. Key Data and Analysis in this report includes: - Detailed Forecasts to 2017 - In-Depth Profiles of the Competitive Companies in Dialysis Treatment, Equipment and Supplies. - Scores of Figures and Tables featuring useful data, demographic and market trends that can be used to supplement internal memos or presentation. - Detailed World Dialysis Market Review including specific reviews of the dialysis service, equipment and supplies market in the United States, Japan, UK, Italy, India, China and Australia and Canada. - Market Share of Major Care and Equipment Providers. - The Changing Regulatory Environment. - Detailed Patient Demographics Current Data, Forecasts and Trends. Issues and trends explored in this study include: - Innovation Pathway at FDA - Dialyzers - Prismaflex System Software - Wearable Artificial Kidney - Implantable Artificial Kidney - Prevalence of Diabetes in Developing Regions - Insurance and Reimbursement Issues - Access to Care for Native Populations - Kidney Transplantation - Product Development and Innovation - Consolidation and Joint Ventures in the Industry - Home Dialysis - Heat Disinfection for Water Quality - Dialysis Treatment Comfort Company Profiles - Asahi Kasei Medical - B.Braun AG - Baxter Healthcare - Bellco - DaVita - Diaverum - Fresenius Medical Care - Fuso Pharmaceutical - Gambro AB - Kawasumi Laboratories - Medionics International - Nikkiso Medical - Nipro Corporation - NxStage Medical For more information visit http://www.researchandmarkets.com/research/9c...rld_market
NXTM: 17.56 (-0.05)
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.
CAH: 86.08 (+0.04), KMB: 111.00 (+0.82), ETRM: 1.21 (+0.06), IVC: 17.13 (+0.15), BAX: 70.39 (+0.31), HRC: 46.88 (+0.14), SYK: 94.51 (+1.14)
